Tuesday, December 23, 2025
ADVT 
National

B.C. commits $2.4B to transit in Metro Vancouver

Darpan News Desk The Canadian Press, 27 May, 2022 02:59 PM
  • B.C. commits $2.4B to transit in Metro Vancouver

VANCOUVER - The B.C. government says a Surrey-to-Langley SkyTrain line and electrified bus fleets are among the projects that will benefit from a $2.4-billion investment in Metro Vancouver transit.

George Heyman, B.C.'s minister responsible for TransLink, announced the funds Friday, saying people throughout Metro Vancouver will have more affordable and convenient travel options, while reducing climate pollution.

The government says in a news release the funds are part of its commitment to cover 40 per cent of the 10-year vision for transit outlined by the regional mayors' council on regional transportation.

The investment plan for TransLink, which is Metro Vancouver's transportation authority, includes expanding transit service, building more bus-priority infrastructure and transitioning bus fleets from diesel to zero-emission vehicles.

The release says the plan will help TransLink replace more than one third of its diesel bus fleet, with about 500 buses that run on electric batteries or natural gas.

On Wednesday, TransLink said its recovery of ridership that plummeted during the pandemic has been stronger than many North American transit networks, but still hasn't returned to previous levels.

It says ridership across its system has rebounded to 70 per cent of pre-pandemic levels after reaching 59 per cent last year.

TransLink CEO Kevin Quinn says in a statement Friday the province's support for the investment plan will ensure the transportation authority is on solid ground while advancing priority projects.

"It has been a challenging few years, and we thank the provincial government for its commitment to ensure transit continues to serve residents throughout Metro Vancouver."

Photo courtesy of IStock. 

MORE National ARTICLES

Emergency powers end but questions linger

Emergency powers end but questions linger
Prime Minister Justin Trudeau announced Wednesday the extraordinary, time-limited powers would be pulled back now that the immediate crisis is over. They were brought in last week to respond to protests and blockades against COVID-19 restrictions and the Liberal government.

Emergency powers end but questions linger

Attempted robbery in Richmond involves snatching of a senior's purse

Attempted robbery in Richmond involves snatching of a senior's purse
One of the occupants of the SUV tried pulling her inside the vehicle and stealing her purse. The suspect or suspects then fled in this vehicle after their attempt was unsuccessful.

Attempted robbery in Richmond involves snatching of a senior's purse

A look at the Omicron subvariant BA.2

A look at the Omicron subvariant BA.2
BA.2 was detected in Canada as early as December, according to Health Canada data, but a report last week from the B.C. COVID-19 modelling group suggests the newer Omicron strain could be spreading faster in parts of the country than the current dominant version, BA.1.

A look at the Omicron subvariant BA.2

Alberta budget set to rebound on high oil prices

Alberta budget set to rebound on high oil prices
 It's budget day in Alberta, and Premier Jason Kenney says there will be a massive infusion of money for the health-care system. Kenney says the COVID-19 pandemic has exposed a system that has too few hospital beds, labs and intensive care spaces.

Alberta budget set to rebound on high oil prices

Trudeau condemns Russia's attack on Ukraine

Trudeau condemns Russia's attack on Ukraine
Trudeau said he would be meeting Thursday with G7 partners and would work quickly with NATO and Canada's allies "to collectively respond to these reckless and dangerous acts, including by imposing significant sanctions in addition to those already announced."

Trudeau condemns Russia's attack on Ukraine

Ottawa approves made-in-Canada COVID vaccine

Ottawa approves made-in-Canada COVID vaccine
Health Canada says its effectiveness and safety in those under 18 and over 64 have "not yet been established." Clinical trials suggested the vaccine was 71 per cent effective in protecting against COVID-19 one week after the second dose. The dosing schedule is 21 days apart.

Ottawa approves made-in-Canada COVID vaccine